Validation of the French Version of the Score on Quality of Life (HiSQOL) in Hidradenitis Suppurativa (QUALIVER)

Regional University Hospital Center (CHRU)

Status: Completed

Conditions: Hidradenitis Suppurativa

Treatments: Other: Verneuil questionnaire Validation

Study type: Observational

Funder types: Other

Identifiers

NCT05986825

29BRC22.0225 (QUALIVER)

Details and patient eligibility

About

Validation of the French Version of the Score on Quality of Life in Hidradenitis Suppurativa. The French HiSQOL will be completed by 60 patients with hidradenitis suppurativa a first time, and a second time 1 week later.

Enrollment: 60 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥18 years
• Patient with Verneuil disease
• Beneficiary of or affiliated to a social security insurance
• Participation agreement

Exclusion criteria

• Patients physically or mentally unable to complete questionnaires.
• Refusal to participate
• Patient under legal protection (guardianship, curatorship) or deprived of liberty

Trial design

60 participants in 1 patient group

Experimental

Description:

Patients with Verneuil disease

Treatment:

Other: Verneuil questionnaire Validation